FADS2 and breast carcinoma: These data indicated that mRNA expression levels of CHKA, FADS2, and SREBF1werehigher in breast cancer samples than in normal breast tissue, and their levels in TNBC were significantly changed compared to ER+ breast cancer samples (Figure 7A).